PsyBio Therapeutics Corp. (PSYB.V) Research

Based in Coconut Creek, Florida, PsyBio Therapeutics Corp. operates as a biotechnology enterprise dedicated to the development, evaluation, and market launch of regulated pharmaceuticals rooted in psychedelic compounds. Its primary objective is to address various mental health issues and other ailments across the United States.

Market snapshot

Symbol
PSYB.V
Price
$0.01
Day change
-25.00%
Market cap
$1.3K
P/E ratio
-0.00x
52-week range
0.005-0.135
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Cognetivity Neurosciences Ltd. (CGN.CN)
  • Ceapro Inc. (CZO.V)
  • HAVN Life Sciences Inc. (HAVN.CN)
  • Irwin Naturals Inc. (IWIN.CN)
  • Lotus Ventures Inc. (J.CN)
  • Newtopia Inc. (NEWU.V)
  • Lumiera Health Inc. (NHP.V)
  • RepliCel Life Sciences Inc. (RP.V)

Open PsyBio Therapeutics Corp. (PSYB.V) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.